Related references
Note: Only part of the references are listed.Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase
John M. Murray et al.
AIDS (2007)
Rapid and durable Antiretroviral effect of the HIV-1 integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection - Results of a 48-week controlled study
Martin Markowitz et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2007)
Plasma HIV-1 RNA dynamics in antiretroviral-naive subjects receiving either triple-nucleoside or efavirenz-containing regimens: ACTG A5166s
Daniel R. Kuritzkes et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia
Frank Maldarelli et al.
PLOS PATHOGENS (2007)
Treatment for adult HIV infection - 2006 recommendations of the International AIDS Society-USA panel
Scott M. Hammer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Residual human immunodeficiency virus type 1 viremia in some patients on Antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells
JR Bailey et al.
JOURNAL OF VIROLOGY (2006)
Two types of cytotoxic lymphocyte regulation explain kinetics of immune response to human immunodeficiency virus
IM Rouzine et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Perils at mucosal front lines for HIV and SIV and their hosts
AT Haase
NATURE REVIEWS IMMUNOLOGY (2005)
Evolution of human immunodeficiency virus under selection and weak recombination
IM Rouzine et al.
GENETICS (2005)
Intermittent HIV-1 viremia (blips) and drug resistance in patients receiving HAART
RE Nettles et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Kinetics of human immunodeficiency virus type 1 decay following entry into resting CD4+ T cells
Y Zhou et al.
JOURNAL OF VIROLOGY (2005)
Emerging drug targets for antiretroviral therapy
JD Reeves et al.
DRUGS (2005)
Complex patterns of viral load decay under antiretroviral therapy: influence of pharmacokinetics and intracellular delay
NM Dixit et al.
JOURNAL OF THEORETICAL BIOLOGY (2004)
Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques
DJ Hazuda et al.
SCIENCE (2004)
Resistance to apoptosis: Mechanism for the development of HIV reservoirs
JJ Lum et al.
CURRENT HIV RESEARCH (2003)
Heterogeneous clearance rates of long-lived lymphocytes infected with HIV:: Intrinsic stability predicts lifelong persistence
MC Strain et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Determining the relative efficacy of highly active antiretroviral therapy
M Louie et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Mathematical models of HIV pathogenesis and treatment
D Wodarz et al.
BIOESSAYS (2002)
Modelling viral and immune system dynamics
AS Perelson
NATURE REVIEWS IMMUNOLOGY (2002)
Correlation between reduction in plasma HIV-1 RNA concentration 1 week after start of antiretroviral treatment and longer-term efficacy
MA Polis et al.
LANCET (2001)
The dependence of viral parameter estimates on the assumed viral life cycle: limitations of studies of viral load data
AL Lloyd
PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2001)
Share Paper
